Point-of-care tests are simple medical tests performed at the bedside or at the clinical laboratory in close immediacy to where the patient is receiving care. It is mainly powered by high-quality and cost-effective medical solutions & technological advancement. It may enhance the management of different diseases & conditions. It is usually performed by non-laboratory persons and results are used for clinical decision making. It is frequently accomplished through the use of portable, transportable, and handheld instruments (nerve conduction study device and blood glucose meter) and test kits (Homocystein, HBA1C, HIV salivary assay, etc.).
According to study, “Global Point of care testing Market Size study, by product (Glucose Monitoring Products, Infectious Disease Testing Products, Cardiometabolic Testing Products, Pregnancy & Fertility Testing Products, Coagulation Testing Products, Tumor/Cancer Marker Testing Products, Pregnancy & Fertility Testing Products, Cholesterol Testing Products, Urinalysis Testing Products, Drugs-of-Abuse Testing Products, Hematology Testing Products, Fecal Occult Testing Products and other POC products ), Platform (Microfluidics, Lateral Flow Assays, Dipsticks, immunoassays, molecular diagnostics) , Mode (OTC-based testing and prescription-based testing) End-user (research laboratories, home care, professional diagnostics centers and other end-users) and Regional Forecasts 2018-2025” the key companies operating in the global point of care testing market are EKF Diagnostics, Johnson & Johnson, Abbott Laboratories, Becton, Dickinson and Company, Accubiotech, Siemens Healthineers, Danaher Corporation, Roche Diagnostics, Quest Diagnostic, Siemens.
Based on product, point of care testing market is segmented into cardio-metabolic monitoring products, glucose monitoring products, infectious disease testing products, pregnancy & fertility testing products, coagulation monitoring products, urinalysis testing products, tumor or cancer market testing products, cholesterol testing products, drugs-of-abuse testing products, hematology testing products, fecal occult testing products and others. Cardio-metabolic monitoring products include blood gas/electrolyte testing products, cardiac marker testing products and Hba 1 c testing products. Glucose monitoring products include meters, strips and lancets & lancing devices. Infectious disease testing products include HIV testing products, influenza testing products, healthcare associated infection testing products, hepatitis C testing products, sexually transmitted disease testing products, tropical disease testing products, respiratory infection testing products and other infectious disease testing products. Pregnancy & fertility testing products include fertility testing products and pregnancy testing products. Additionally, coagulation monitoring products include Activated Clotting Time (ACT/APTT) Testing Kits and Prothrombin Time (PT/INR) Testing Kits. Based on mode of prescription, market is segmented intoC Over-the-ounter (OTC) products and prescription based products. Based on distribution channel, market is segmented into retail and direct tenders. In addition, based on end-user, market is segmented into hospitals/critical care centers, professional diagnostic centers, research laboratories, home care settings and others.
The point of care testing market is driven by rise in incidence of target conditions, followed by high prevalence of infectious diseases in developing countries, increase in international research collaborations, shortage of skilled laboratory technicians, growth in government support and rise in number of Clia-Waived POC tests. However, stringent & time-consuming regulatory policies and lack of alignment with definitive central lab methods may impact the market. Moreover, POC tests with multiplexing capabilities and rise in awareness through conferences & events are key opportunities for market.
Based on geography, the North-American region holds the leading position in point of care testing market owing to rise in healthcare expenditure and high awareness amongst healthcare providers & patients regarding early disease diagnosis in the region. Whereas, the Asian-Pacific region is estimated to witness higher growth rate due to growth in companies engaged in exploiting the untapped opportunities over the forecast period.
For more information, click on the link below:
Ankur Gupta, Head Marketing & Communications